Amit Bar-Or

Professor

University of Pennsylvania

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Amit Bar-Or is a Professor at the University of Pennsylvania, USA. His research primarily focuses on multiple sclerosis, with recent publications exploring topics such as brain atrophy, clinical utility of neurofilament light chain assays, and the effects of various disease-modifying therapies. He is also involved in studies concerning treatment algorithms and safety in clinical applications for both relapsing and progressive multiple sclerosis.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (2)

Manuel Comabella

SPAIN

View details

Ludwig Kappos

Professor

University of Basel

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amit Bar-Or

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study

Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials

Exploring the Clinical Utility of Neurofilament Light Chain Assays in Multiple Sclerosis Management

Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS

Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study

Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients

Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis

Choroid Plexus Volume in Pediatric-Onset Multiple Sclerosis

Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents

Cloning and Functional Characterization of Novel Human Neutralizing Anti–IFN-α and Anti–IFN-β Antibodies

Collaborators (2)

Manuel Comabella

Ludwig Kappos

Make your next move.